X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://endpts.com/merck-defends-antibiotics-approval-from-2019-as-bmj-investigation-points-to-decline-in-fda-standards/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.fiercepharma.com/pharma/merck-telegraphs-closure-pa-antibiotics-plant-employs-300
http://www.pharmatimes.com/news/novel_antibiotic_recarbrio_has_launched_in_the_uk_1357341
https://investors.merck.com/news/press-release-details/2020/FDA-Approves-Mercks-RECARBRIO-imipenem-cilastatin-and-relebactam-for-the-Treatment-of-Adults-with-Hospital-Acquired-and-Ventilator-Associated-Bacterial-Pneumonia-HABPVABP/default.aspx
https://www.businesswire.com/news/home/20200506005158/en/Results-Phase-3-Trial-Evaluating-Efficacy-Safety
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-december-2019
https://www.fiercepharma.com/marketing/aiming-for-label-expansion-merck-touts-new-trial-results-for-antibiotic-recarbrio
https://www.biospace.com/article/merck-s-recarbrio-shows-success-in-late-stage-trial-for-habp-vabp-patients/
https://endpts.com/merck-touts-phase-iii-data-for-antibacterial-recarbrio-sanofi-to-ax-200-jobs-in-japan-report/
https://www.fiercepharma.com/pharma/as-officials-grapple-antimicrobial-resistance-merck-scores-fda-approval-for-new
https://in.reuters.com/article/us-merck-co-fda/mercks-treatment-for-urinary-abdominal-infections-gets-fda-approval-idINKCN1UC19W
https://www.biospace.com/article/fda-action-alert-karyopharm-merck-and-celgene/
https://www.fiercepharma.com/pharma/merck-scores-zerbaxa-label-expansion-years-after-cubist-buyout
http://www.pharmatimes.com/news/fda_accepts_two_of_msds_new_drug_applications_1277462
https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-pvt-ltd-on-fda-import-alert-list-1549480434.pdf
http://www.prnewswire.com/news-releases/shionogi-announces-positive-top-line-results-for-cefiderocol-pivotal-cuti-clinical-trial-300389912.html
https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-private-limited-fails-edqm-inspection-1471672382.pdf
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0346-2015&w=01282015&lang=eng
Market Place
Share 
